Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05485701
Other study ID # 10-20
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2022
Est. completion date August 31, 2026

Study information

Verified date November 2023
Source University of Oxford
Contact Gracia Fellmeth, DPhil
Phone 00441865289745
Email gracia.fellmeth@ndph.ox.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.


Description:

The purpose of this observational study is to assess the mental health of perinatal women living in two low-income settings in India. The first phase will explore women's awareness of mental illness and acceptability of screening for mental disorders. The second phase will be a validation study, during which the psychometric properties of screening tools will be assessed against a gold standard. The third stage will comprise a cohort study, during which the prevalence of and risk factors for mental disorders among perinatal and non-perinatal women will be established.


Recruitment information / eligibility

Status Recruiting
Enrollment 2332
Est. completion date August 31, 2026
Est. primary completion date August 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: For Phase 1 (qualitative study) and Phase 2 (validation study): Pregnant women: - Aged 18 to 45 years - Currently pregnant (any trimester) - Willing and able to give informed consent Post-partum women: - Aged 18 to 45 years - Currently post-partum (between 1-12 months postpartum) - Willing and able to give informed consent Non-perinatal women: - Aged 18 to 45 years - Not currently pregnant and not given birth in the past 12 months - Willing and able to give informed consent For Phase 3 (prospective cohort study): Perinatal women: - Aged 18 to 45 years - In early pregnancy (estimated gestational age <20 weeks) at recruitment - Not planning to relocate for the duration of the study period - Willing and able to give informed consent - Expressed a willingness to continue to participate for the four planned visits Non-perinatal women: - Aged 18 to 45 years - Not currently pregnant and not given birth in the last 12 months - Not planning to relocate for the duration of the study period - Willing and able to give informed consent - Expressed a willingness to continue to participate for the four planned visits Exclusion Criteria: The participant may not enter the study if: - They have an acutely severe psychiatric illness which impairs their ability to take part in the study - They are not willing or able to provide informed consent Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Screening tools for common mental disorders
A number of screening tools will be administered which will establish the likelihood of depression, anxiety, PTSD, somatisation and suicidality.

Locations

Country Name City State
India National Institute of Mental Health and Neuro Sciences Bengaluru Karnataka
India Dr Rajendra Prasad Government Medical College Kangra Himachal Pradesh

Sponsors (3)

Lead Sponsor Collaborator
University of Oxford Dr. Rajendra Prasad Government Medical College, National Institute of Mental Health and Neuro Sciences, India

Country where clinical trial is conducted

India, 

References & Publications (1)

Fellmeth G, Kishore MT, Verma A, Desai G, Bharti O, Kanwar P, Singh S, Thippeswamy H, Chandra PS, Kurinczuk JJ, Nair M, Alderdice F. Perinatal mental health in India: protocol for a validation and cohort study. J Public Health (Oxf). 2021 Oct 8;43(Suppl 2):ii35-ii42. doi: 10.1093/pubmed/fdab162. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disorders These will be themes emerging from focus groups with women around awareness of perinatal mental disorders and acceptability of screening. To be completed by August 2022
Primary Phase 2: Psychometric properties of screening tools for common mental disorders The psychometric properties (sensitivity, specificity, area under the receiver operating curve, optimal cut-off and accuracy) of eight screening tools in Kannada and Hindi will be established among three groups of women: pregnant, post-partum and non-perinatal. September 2022 - August 2023
Primary Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal women During the cohort study, prevalence and incidence of mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed. September 2023 - August 2024
Primary Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women During the cohort study, risk factors associated with mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed. September 2023 - August 2024
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A